94 related articles for article (PubMed ID: 25636360)
21. Opening the psychological black box in genetic counseling. The psychological impact of DNA testing is predicted by the counselees' perception, the medical impact by the pathogenic or uninformative BRCA1/2-result.
Vos J; Gómez-García E; Oosterwijk JC; Menko FH; Stoel RD; van Asperen CJ; Jansen AM; Stiggelbout AM; Tibben A
Psychooncology; 2012 Jan; 21(1):29-42. PubMed ID: 21072753
[TBL] [Abstract][Full Text] [Related]
22. Attitudes toward colon cancer gene testing: survey of relatives of colon cancer patients.
Petersen GM; Larkin E; Codori AM; Wang CY; Booker SV; Bacon J; Giardiello FM; Boyd PA
Cancer Epidemiol Biomarkers Prev; 1999 Apr; 8(4 Pt 2):337-44. PubMed ID: 10207638
[TBL] [Abstract][Full Text] [Related]
23. Prophylactic Oophorectomy: Reducing the U.S. Death Rate from Epithelial Ovarian Cancer. A Continuing Debate.
Piver MS
Oncologist; 1996; 1(5):326-330. PubMed ID: 10388011
[TBL] [Abstract][Full Text] [Related]
24. Attitudes of high-risk women toward preimplantation genetic diagnosis.
Quinn G; Vadaparampil S; Wilson C; King L; Choi J; Miree C; Friedman S
Fertil Steril; 2009 Jun; 91(6):2361-8. PubMed ID: 18440521
[TBL] [Abstract][Full Text] [Related]
25. Legal and ethical issues in genetic testing and counseling for susceptibility to breast, ovarian and colon cancer.
Dickens BM; Pei N; Taylor KM
CMAJ; 1996 Mar; 154(6):813-8. PubMed ID: 8634959
[TBL] [Abstract][Full Text] [Related]
26. Health-related quality of life in early breast cancer.
Groenvold M
Dan Med Bull; 2010 Sep; 57(9):B4184. PubMed ID: 20816024
[TBL] [Abstract][Full Text] [Related]
27. Five families living with hereditary breast and ovarian cancer risk.
Norris J; Spelic SS; Snyder C; Tinley S
Clin J Oncol Nurs; 2009 Feb; 13(1):73-80. PubMed ID: 19193551
[TBL] [Abstract][Full Text] [Related]
28. The influence of dispositional optimism on post-visit anxiety and risk perception accuracy among breast cancer genetic counselees.
Wiering BM; Albada A; Bensing JM; Ausems MG; van Dulmen AM
Psychooncology; 2013 Nov; 22(11):2419-27. PubMed ID: 23630180
[TBL] [Abstract][Full Text] [Related]
29. Direct contact in inviting high-risk members of hereditary colon cancer families to genetic counselling and DNA testing.
Aktan-Collan K; Haukkala A; Pylvänäinen K; Järvinen HJ; Aaltonen LA; Peltomäki P; Rantanen E; Kääriäinen H; Mecklin JP
J Med Genet; 2007 Nov; 44(11):732-8. PubMed ID: 17630403
[TBL] [Abstract][Full Text] [Related]
30. [Psychosocial impact of the first oncogenetic consultation in a familial context of cancers of the breast and the ovary].
Blandy C; Schwab S; Stoppa-Lyonnet D; Dazord A
Bull Cancer; 1998 Jul; 85(7):637-43. PubMed ID: 9752272
[TBL] [Abstract][Full Text] [Related]
31. Nonverbal communication and conversational contribution in breast cancer genetic counseling: are counselors' nonverbal communication and conversational contribution associated with counselees' satisfaction, needs fulfillment and state anxiety in breast cancer genetic counseling?
Dijkstra H; Albada A; Klöckner Cronauer C; Ausems MG; van Dulmen S
Patient Educ Couns; 2013 Nov; 93(2):216-23. PubMed ID: 23786807
[TBL] [Abstract][Full Text] [Related]
32. The need for oncogenetic counselling. Ten years' experience of a regional oncogenetic clinic.
Henriksson K; Olsson H; Kristoffersson U
Acta Oncol; 2004; 43(7):637-49. PubMed ID: 15545184
[TBL] [Abstract][Full Text] [Related]
33. Disclosure to the family of breast/ovarian cancer genetic test results: patient's willingness and associated factors.
Julian-Reynier C; Eisinger F; Chabal F; Lasset C; Noguès C; Stoppa-Lyonnet D; Vennin P; Sobol H
Am J Med Genet; 2000 Sep; 94(1):13-8. PubMed ID: 10982476
[TBL] [Abstract][Full Text] [Related]
34. How to support cancer genetics counselees in informing at-risk relatives? Lessons from a randomized controlled trial.
Eijzenga W; de Geus E; Aalfs CM; Menko FH; Sijmons RH; de Haes HCJM; Smets EMA
Patient Educ Couns; 2018 Sep; 101(9):1611-1619. PubMed ID: 29789176
[TBL] [Abstract][Full Text] [Related]
35. The development of a cancer genetic-specific measure of coping: the GRACE.
Phelps C; Bennett P; Jones H; Hood K; Brain K; Murray A
Psychooncology; 2010 Aug; 19(8):847-54. PubMed ID: 19823974
[TBL] [Abstract][Full Text] [Related]
36. Informational and emotional support received by relatives before and after the cancer patient's death.
Eriksson E; Arve S; Lauri S
Eur J Oncol Nurs; 2006 Feb; 10(1):48-58. PubMed ID: 16006186
[TBL] [Abstract][Full Text] [Related]
37. Social sharing of genetic information in the family: a study on hereditary breast and ovarian cancers.
Christophe V; Vennin P; Corbeil M; Adenis C; Reich M
J Health Psychol; 2009 Oct; 14(7):855-60. PubMed ID: 19786511
[TBL] [Abstract][Full Text] [Related]
38. Is there a "right time" for bad news? Kairos in familial communication on hereditary breast and ovarian cancer risk.
Derbez B
Soc Sci Med; 2018 Apr; 202():13-19. PubMed ID: 29500986
[TBL] [Abstract][Full Text] [Related]
39. Development of the Informing Relatives Inventory (IRI): Assessing Index Patients' Knowledge, Motivation and Self-Efficacy Regarding the Disclosure of Hereditary Cancer Risk Information to Relatives.
de Geus E; Aalfs CM; Menko FH; Sijmons RH; Verdam MG; de Haes HC; Smets EM
Int J Behav Med; 2015 Aug; 22(4):551-60. PubMed ID: 25515913
[TBL] [Abstract][Full Text] [Related]
40. Ethical issues in cancer genetics: I 1) whose information is it?
Schneider KA; Chittenden AB; Branda KJ; Keenan MA; Joffe S; Patenaude AF; Reynolds H; Dent K; Eubanks S; Goldman J; Leroy B; Warren NS; Taylor K; Vockley CW; Garber JE
J Genet Couns; 2006 Dec; 15(6):491-503. PubMed ID: 17106632
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
